WHO ICTRP trial
Asarun versus Sumbul ul teeb in Premenstrual symptoms associated with…
CTRI/2025/02/081003 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/02/081003 |
|---|---|
| Public title | Asarun versus Sumbul ul teeb in Premenstrual symptoms associated with menstraution |
| Scientific title | Efficacy of Asarun versus Sumbul ul teeb in Premenstrual Syndrome- A randomised clinical study |
| Primary sponsor | National Institute of Unani Medicine |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: N943- Premenstrual tension syndrome |
| Interventions | Intervention1: Asarun: Asarun 3 gm daily orally in 2 divided doses from 15 day prior to the expected menstrual cycle for 3 consequent cycles Control Intervention1: Sumbul-ut-teeb: Sumbul-ut-teeb 4 gm daily orally in 2 divided doses from 15… |
| Registration date | Feb 20, 2025 |
| Target size | 64 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: